# INOZYME PHARMA INC (INZY)

> Institutional ownership reported to the SEC as of Q2 2025, from Form 13F filings. Source: https://holderbook.com/stocks/INZY/

- Reporting holders: 88
- Reported value: $203.1M
- Held through calls: 0.4%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Beryl Capital Management LLC](https://holderbook.com/funds/1719307-beryl-capital-management-llc/) | $25.3M | 6,321,584 | 3.8% | 1 |
| [Pivotal bioVenture Partners Investment Advisor LLC](https://holderbook.com/funds/1844645-pivotal-bioventure-partners-investment-advisor-llc/) | $18.0M | 4,494,851 | 11.1% | 19 |
| [GLAZER CAPITAL, LLC](https://holderbook.com/funds/1076809-glazer-capital-llc/) | $17.3M | 4,330,220 | 0.6% | 1 |
| [Sofinnova Investments, Inc.](https://holderbook.com/funds/1631134-sofinnova-investments-inc/) | $17.1M | 4,280,308 | 1.0% | 20 |
| [ODDO BHF ASSET MANAGEMENT SAS](https://holderbook.com/funds/1686970-oddo-bhf-asset-management-sas/) | $12.8M | 3,200,000 | 0.5% | 1 |
| [Trium Capital LLP](https://holderbook.com/funds/1963860-trium-capital-llp/) | $12.7M | 3,173,454 | 3.2% | 1 |
| [BlackRock, Inc.](https://holderbook.com/funds/2012383-blackrock-inc/) | $10.7M | 2,663,678 | 0.0% | 4 |
| [VANGUARD GROUP INC](https://holderbook.com/funds/102909-vanguard-group-inc/) | $10.0M | 2,498,649 | 0.0% | 20 |
| [NEA Management Company, LLC](https://holderbook.com/funds/1512848-nea-management-company-llc/) | $9.8M | 2,437,689 | 0.7% | 20 |
| [ALPINE ASSOCIATES MANAGEMENT INC.](https://holderbook.com/funds/1396835-alpine-associates-management-inc/) | $8.8M | 2,188,100 | 0.5% | 1 |
| [Affinity Asset Advisors, LLC](https://holderbook.com/funds/1773195-affinity-asset-advisors-llc/) | $7.0M | 1,749,359 | 1.0% | 11 |
| [GABELLI FUNDS LLC](https://holderbook.com/funds/1081407-gabelli-funds-llc/) | $5.8M | 1,457,800 | 0.0% | 1 |
| [GARDNER LEWIS ASSET MANAGEMENT L P](https://holderbook.com/funds/941560-gardner-lewis-asset-management-l-p/) | $5.0M | 1,257,765 | 1.3% | 1 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $4.9M | 1,221,125 | 0.0% | 20 |
| [OMERS ADMINISTRATION Corp](https://holderbook.com/funds/1053321-omers-administration-corp/) | $4.5M | 1,116,800 | 0.0% | 1 |
| [Man Group plc](https://holderbook.com/funds/1637460-man-group-plc/) | $2.7M | 670,155 | 0.0% | 1 |
| [Knott David M Jr](https://holderbook.com/funds/1892770-knott-david-m-jr/) | $2.7M | 666,204 | 1.2% | 10 |
| [GABELLI & Co INVESTMENT ADVISERS, INC.](https://holderbook.com/funds/932724-gabelli-co-investment-advisers-inc/) | $2.5M | 617,000 | 0.4% | 1 |
| [Woodline Partners LP](https://holderbook.com/funds/1784547-woodline-partners-lp/) | $2.1M | 535,185 | 0.0% | 7 |
| [MILLENNIUM MANAGEMENT LLC](https://holderbook.com/funds/1273087-millennium-management-llc/) | $1.9M | 481,799 | 0.0% | 13 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $1.9M | 470,500 | 0.0% | 14 |
| [Sanofi](https://holderbook.com/funds/1121404-sanofi/) | $1.8M | 443,255 | 1.0% | 3 |
| [Skandinaviska Enskilda Banken AB (publ)](https://holderbook.com/funds/1534653-skandinaviska-enskilda-banken-ab-publ/) | $1.5M | 377,227 | 0.0% | 1 |
| [OXFORD ASSET MANAGEMENT LLP](https://holderbook.com/funds/1438284-oxford-asset-management-llp/) | $1.4M | 361,557 | 0.5% | 1 |
| [STATE STREET CORP](https://holderbook.com/funds/93751-state-street-corp/) | $1.3M | 331,772 | 0.0% | 20 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2025 | 88 | $203.1M |
| Q1 2025 | 97 | $42.5M |
| Q4 2024 | 104 | $145.3M |
| Q3 2024 | 88 | $285.7M |
| Q2 2024 | 89 | $240.3M |
| Q1 2024 | 88 | $384.7M |
| Q4 2023 | 82 | $215.5M |
| Q3 2023 | 78 | $205.9M |
| Q2 2023 | 74 | $190.7M |
| Q1 2023 | 50 | $188.0M |
| Q4 2022 | 35 | $30.4M |
| Q3 2022 | 36 | $84.6M |